Comparison of the Pharmacokinetics, Safety, and Tolerability of the Autoinjector
Comparison of the Pharmacokinetics, Safety, and Tolerability of the Autoinjector
About this item
Full title
Author / Creator
Publisher
Dove Medical Press Limited
Journal title
Language
English
Formats
Publication information
Publisher
Dove Medical Press Limited
Subjects
More information
Scope and Contents
Contents
Purpose: SB4 is an etanercept biosimilar, approved by the European Commission (EC) and the US Food and Drug Administration (FDA) following a demonstration of equivalent efficacy and safety and comparable quality data to the reference product. This study aimed to demonstrate equivalent pharmacokinetic (PK) profiles, safety, and tolerability between...
Alternative Titles
Full title
Comparison of the Pharmacokinetics, Safety, and Tolerability of the Autoinjector
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_healthsolutions_A614348865
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_healthsolutions_A614348865
Other Identifiers
ISSN
1177-8881
E-ISSN
1177-8881
